GlassScriptPhysician profile
Steven A Gersh
NPI 1942313176
$1,811.32
in general payments reported to CMS, 2019-2025
26 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $43.57 · 2021: $372 · 2022: $202 · 2023: $194 · 2024: $182 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $14.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.32 |
| Education | $14.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $391.61 | 2021-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $297.64 | 2019-2021 | |
| Organogenesis INC. | $157.96 | 2020-2025 | Cygnus Dual |
| Nevro Corp. | $144.20 | 2023 | Senza |
| Treace Medical Concepts, INC. | $106.56 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $100.64 | 2019-2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $93.25 | 2019-2022 | |
| Horizon Therapeutics Plc | $49.88 | 2022 | |
| Ani Pharmaceuticals, INC. | $46.55 | 2025 | Purified Cortrophin Gel |
| Stryker Corporation | $36.95 | 2022 | |
| Hikma Pharmaceuticals USA | $30.48 | 2019 | |
| Nabriva Therapeutics, Plc | $28.94 | 2021 | |
| Sebela Pharmaceuticals INC. | $28.49 | 2020-2021 | |
| Ossio INC | $27.48 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $21.77 | 2025 | Nimbl, Flexitouch Plus |
| Bioventus LLC | $19.72 | 2024 | Exogen Ultrasound Bone Healing System |
| Solventum Corporation | $18.97 | 2025 | Activ.A.C. |
| Convatec INC. | $17.50 | 2023 | |
| Averitas Pharma INC. | $16.57 | 2025 | Qutenza |
| Globus Medical, INC. | $16.43 | 2025 | Senza |
| Heron Therapeutics, INC. | $15.89 | 2021 | |
| Lifenet Health | $14.50 | 2024 | Theragenesis Wound Matrix |
| Wright Medical Technology, INC. | $11.96 | 2019 | |
| Medtronic Vascular, INC. | $11.38 | 2020 | |
| Glenmark Therapeutics INC. | $6.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Gersh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.